Image

Effect of Person-Centered Occupational Therapy Interventions for Substance Use Disorder

Effect of Person-Centered Occupational Therapy Interventions for Substance Use Disorder

Recruiting
18-65 years
All
Phase N/A

Powered by AI

Overview

This study investigates the impact of person-centered occupational therapy interventions on individuals diagnosed with substance use disorder. Substance use often leads to isolation and difficulties in daily activities such as work, self-care, and leisure time. The research aims to evaluate how a tailored 8-week therapy program affects participants' occupational performance, self-efficacy, and psychological resilience. Participants will be divided into a study group receiving therapy and a control group.

Description

Participants aged 18-65 with a DSM-5 diagnosis of substance use disorder will be recruited from the Erenköy AMATEM unit. The study employs an experimental design with 34 participants (17 in the study group, 17 in the control group). The study group will receive person-centered occupational therapy interventions 3 times per week for a total of 8 weeks.

The intervention process is based on the four stages of person-centered practice: identifying occupational performance problems using the Canadian Occupational Performance Measure (COPM), brainstorming realistic goals, implementing tailored strategies (e.g., time management, vocational skills, or healthy habits), and revising the process based on feedback . Assessment tools including the COPM, Self-Efficacy Scale, and Brief Resilience Scale will be administered at baseline and after the 8-week intervention to measure changes in performance and psychological factors.

Eligibility

Inclusion Criteria:

  • Being diagnosed with substance use disorder according to DSM-5 criteria.
  • Having completed the detoxification process.
  • Being between the ages of 18-65.
  • Having at least a primary school education.
  • Volunteering to participate and signing the informed consent.

Exclusion Criteria:

  • Being in an acute psychotic episode.
  • Having severe neurological deficits that prevent responding to assessments. -Having severe visual or hearing loss that prevents completing the test batteries

Study details
    Substance Use Disorder (SUD)

NCT07364240

Hacettepe University

31 January 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.